Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
Sheila Lumley, Denise O’Donnell, Nicole Stoesser, et al.
New England Journal of Medicine (2020) Vol. 384, Iss. 6, pp. 533-540
Open Access | Times Cited: 976

Showing 1-25 of 976 citing articles:

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
David S. Khoury, Deborah Cromer, Arnold Reynaldi, et al.
Nature Medicine (2021) Vol. 27, Iss. 7, pp. 1205-1211
Open Access | Times Cited: 3736
Adaptive immunity to SARS-CoV-2 and COVID-19
Alessandro Sette, Shane Crotty
Cell (2021) Vol. 184, Iss. 4, pp. 861-880
Open Access | Times Cited: 1754
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
Allison J. Greaney, Andrea N. Loes, Katharine H. D. Crawford, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 3, pp. 463-476.e6
Open Access | Times Cited: 1218
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
Shuo Feng, Daniel J. Phillips, Thomas B. White, et al.
Nature Medicine (2021) Vol. 27, Iss. 11, pp. 2032-2040
Open Access | Times Cited: 1105
Evidence for antibody as a protective correlate for COVID-19 vaccines
Kristen Earle, Donna M. Ambrosino, Andrew Fioré-Gartland, et al.
Vaccine (2021) Vol. 39, Iss. 32, pp. 4423-4428
Open Access | Times Cited: 890
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
Markus Hoffmann, Nadine Krüger, Sebastian Schulz, et al.
Cell (2021) Vol. 185, Iss. 3, pp. 447-456.e11
Open Access | Times Cited: 870
Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence
Éster Cerdeira Sabino, Lewis Buss, Maria P. S. S. Carvalho, et al.
The Lancet (2021) Vol. 397, Iss. 10273, pp. 452-455
Open Access | Times Cited: 856
Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study
Christian Holm Hansen, Daniela Michlmayr, Sophie Gubbels, et al.
The Lancet (2021) Vol. 397, Iss. 10280, pp. 1204-1212
Open Access | Times Cited: 643
mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
Leonidas Stamatatos, Julie Czartoski, Yu-Hsin Wan, et al.
Science (2021) Vol. 372, Iss. 6549, pp. 1413-1418
Open Access | Times Cited: 578
Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2
Joseph E. Ebinger, Justyna Fert‐Bober, Ignat Printsev, et al.
Nature Medicine (2021) Vol. 27, Iss. 6, pp. 981-984
Open Access | Times Cited: 578
Enhanced SARS-CoV-2 neutralization by dimeric IgA
Zijun Wang, Julio C. C. Lorenzi, Frauke Muecksch, et al.
Science Translational Medicine (2020) Vol. 13, Iss. 577
Open Access | Times Cited: 462
The first 12 months of COVID-19: a timeline of immunological insights
Thiago de Amorim Carvalho, Florian Krammer, Akiko Iwasaki
Nature reviews. Immunology (2021) Vol. 21, Iss. 4, pp. 245-256
Open Access | Times Cited: 424
SARS-CoV-2 Variants in Patients with Immunosuppression
Lawrence Corey, Chris Beyrer, Myron S. Cohen, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 6, pp. 562-566
Open Access | Times Cited: 410
Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom
Jia Wei, Nicole Stoesser, Philippa C. Matthews, et al.
Nature Microbiology (2021) Vol. 6, Iss. 9, pp. 1140-1149
Open Access | Times Cited: 311
Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis
Ayelet Grupper, Nechama Sharon, Talya Finn, et al.
Clinical Journal of the American Society of Nephrology (2021) Vol. 16, Iss. 7, pp. 1037-1042
Open Access | Times Cited: 310
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells
José Mateus, Jennifer M. Dan, Zeli Zhang, et al.
Science (2021) Vol. 374, Iss. 6566
Open Access | Times Cited: 292
Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination
Alice Cho, Frauke Muecksch, Dennis Schaefer-Babajew, et al.
Nature (2021) Vol. 600, Iss. 7889, pp. 517-522
Open Access | Times Cited: 276
Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection
Raymond A. Harvey, Jeremy A. Rassen, Carly Kabelac, et al.
JAMA Internal Medicine (2021) Vol. 181, Iss. 5, pp. 672-672
Open Access | Times Cited: 273
Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients
Héctor Rincón-Arévalo, Mira Choi, Ana‐Luisa Stefanski, et al.
Science Immunology (2021) Vol. 6, Iss. 60, pp. eabj1031-eabj1031
Open Access | Times Cited: 265
Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection
Deborah Cromer, Jennifer A. Juno, David S. Khoury, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 6, pp. 395-404
Open Access | Times Cited: 259
Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study
Kazimieras Maneikis, Karolis Šablauskas, Ugnė Ringelevičiūtė, et al.
The Lancet Haematology (2021) Vol. 8, Iss. 8, pp. e583-e592
Open Access | Times Cited: 234
SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity
Stefan Pilz, Verena Theiler‐Schwetz, Christian Trummer, et al.
Environmental Research (2022) Vol. 209, pp. 112911-112911
Open Access | Times Cited: 234
Correlates of protection against SARS‐CoV‐2 infection and COVID‐19 disease
David Goldblatt, Galit Alter, Shane Crotty, et al.
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 6-26
Open Access | Times Cited: 234
Three waves changes, new variant strains, and vaccination effect against COVID-19 pandemic
Rehan M. El-Shabasy, Mohamed Nayel, Mohamed M. Taher, et al.
International Journal of Biological Macromolecules (2022) Vol. 204, pp. 161-168
Open Access | Times Cited: 229
A human coronavirus evolves antigenically to escape antibody immunity
Rachel Eguia, Katharine H. D. Crawford, Terry Stevens-Ayers, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 4, pp. e1009453-e1009453
Open Access | Times Cited: 221
Page 1 - Next Page

Scroll to top